Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$270.24+2.87 (+1.07%)
At close: Aug 21, 2026, 4:00 PM ET
Drug Manufacturers - General · New Brunswick, NJ
At close: Aug 21, 2026, 4:00 PM ET
Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 23.33.
Forward PE Ratio (23.33) = Close Price ($270.24) / Consensus Forward EPS ($11.59)
FORWARD PE RATIO
23.33
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+17.15%
vs the sector median at left
Johnson & Johnson
Market Cap
$651.25B
Forward PE Ratio
23.33
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Johnson & Johnson (JNJ) | $651.25B | 23.33 |
| Pfizer Inc. (PFE)vs › | $159.98B | 9.44 |
| Merck & Co., Inc. (MRK)vs › | $376.77B | 55.50 |
| AbbVie Inc. (ABBV)vs › | $468.22B | 18.88 |
| Eli Lilly and Company (LLY)vs › | $1.18T | 34.49 |
| Bristol-Myers Squibb Company (BMY)vs › | $136.88B | 9.67 |
Trailing P/E
31.3
reported TTM EPS
Forward P/E
23.3
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $11.59 implies +34.3% EPS growth vs the reported trailing $8.63.
At today's $270.24 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| 2026-12-28 | $11.59 | $11.02 – $11.89 | 4 | 23.3x |
| 2027-12-28 | $12.75 | $12.20 – $13.48 | 4 | 21.2x |
| 2028-12-28 | $14.25 | $10.69 – $16.48 | 5 | 19.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.